These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19828329)

  • 1. The effect of salt concentration on the prekallikrein activator assay.
    Georgakopoulos T; Bertolini J; Hayes TK
    Biologicals; 2010 Jan; 38(1):178-9. PubMed ID: 19828329
    [No Abstract]   [Full Text] [Related]  

  • 2. A collaborative study to establish the 1st national standard of prekallikrein activator in Korea.
    Shin IS; Hong CM; Ban SJ; Hong SH
    Biologicals; 2012 Jan; 40(1):79-83. PubMed ID: 22122985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of immunoglobulin concentrates on thrombogenic activity by thrombin generation assay, prekallikrein activator assay, and size-exclusion chromatography.
    Seifner A; Beck G; Bayer P; Eichmeir S; Lackner F; Rögelsperger O; Weber K; Wollein G
    Transfusion; 2014 Feb; 54(2):376-83. PubMed ID: 23772713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIIa is a kinetically favorable plasminogen activator.
    Schousboe I; Feddersen K; Røjkjaer R
    Thromb Haemost; 1999 Sep; 82(3):1041-6. PubMed ID: 10494761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved, reliable and practical kinetic assay for the detection of prekallikrein activator in blood products.
    Shin IS; Shim YB; Hong CM; Koh HC; Lee SH; Hong SH
    Arch Pharm Res; 2002 Aug; 25(4):505-10. PubMed ID: 12214864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical application of a chromogenic FXIIa assay.
    Zhuo R; Vogler EA
    Biomaterials; 2006 Oct; 27(28):4840-5. PubMed ID: 16765435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an updated assay for prekallikrein activator in albumin and immunoglobulin therapeutics.
    Roberts G; Fox B; Longstaff C
    Vox Sang; 2021 Jan; 116(1):99-105. PubMed ID: 32986885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of prekallikrein activator (PKA) activity in plasma-derived preparations].
    Miks B; Aleksandrowicz J; Kawiak J
    Med Dosw Mikrobiol; 1990; 42(3-4):171-7. PubMed ID: 2128105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro assay for prekallikrein activator (PKA).
    Lundblad JL
    Dev Biol Stand; 1979; 44():107-14. PubMed ID: 317466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assay of prekallikrein activator in human blood products.
    Snape TJ; Griffith D; Vallet L; Wesley ED
    Dev Biol Stand; 1979; 44():115-20. PubMed ID: 317467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated factor XII in rheumatoid arthritis.
    McLaren M; Alkaabi J; Connacher M; Belch JJ; Valenete E
    Rheumatol Int; 2002 Sep; 22(5):182-4. PubMed ID: 12215862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the factor XIIa assay kit].
    Munakata M; Komiyama Y; Mori T; Okuda K; Murakami T; Masuda M; Egawa H; Takahashi H
    Rinsho Byori; 1996 Sep; 44(9):883-8. PubMed ID: 8911075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A renaissance for the contact system in blood coagulation?
    Blat Y; Seiffert D
    Thromb Haemost; 2008 Mar; 99(3):457-60. PubMed ID: 18327389
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta.
    Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F
    J Immunol Methods; 2007 Apr; 321(1-2):19-31. PubMed ID: 17335844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.
    van Waarde MA; van Assen AJ; Kampinga HH; Konings AW; Vujaskovic Z
    Anal Biochem; 1997 Apr; 247(1):45-51. PubMed ID: 9126369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the sensitivity of a biologic assay for mutagenicity.
    Workman ML; Livingston GK
    Nurs Res; 1993; 42(6):373-5. PubMed ID: 8247822
    [No Abstract]   [Full Text] [Related]  

  • 17. Standardization and simplified application of the rat ovarian augmentation test.
    Provos-Calliga B; Van Elteren P
    Acta Eur Fertil; 1972 Mar; 3(1):71-8. PubMed ID: 4679716
    [No Abstract]   [Full Text] [Related]  

  • 18. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of instruments on lupus anticoagulant testing.
    Exner T; Hohnen-Behrens C; Newman P; Dargan W
    Thromb Haemost; 2000 Feb; 83(2):345-8. PubMed ID: 10739397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.